PFBT
JANX icon

Parkside Financial Bank & Trust’s Janux Therapeutics JANX Stock Holding History

Parkside Financial Bank & Trust’s Portfolio JANX Stock Details JANX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$278 Hold
20
– – ﹤0.01% 2624
2025
Q4 		$276 Buy
+20
New +$470 ﹤0.01% 2624

Other funds holding JANX

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Parkside Financial Bank & Trust's JANX Position: Q1 2026 in Review

Parkside Financial Bank & Trust held its Janux Therapeutics (JANX) position steady in Q1 2026 at 20 shares worth $278. The position accounts for ﹤0.01% of the portfolio, ranked #2624.

Parkside Financial Bank & Trust first reported a position in JANX in Q4 2025 and has held it in 2 quarters since. 190 funds tracked by Wall St. Rank hold JANX as of Q1 2026.

  • Parkside Financial Bank & Trust held 20 shares of Janux Therapeutics worth $278 as of Q1 2026.
  • Parkside Financial Bank & Trust left its Janux Therapeutics share count unchanged in Q1 2026.
  • Janux Therapeutics made up ﹤0.01% of Parkside Financial Bank & Trust's portfolio in Q1 2026, its #2624 holding.
  • Parkside Financial Bank & Trust first reported a position in Janux Therapeutics in Q4 2025 and has held it in 2 quarters since.
  • 190 funds tracked by Wall St. Rank held Janux Therapeutics as of Q1 2026.

Based on Parkside Financial Bank & Trust's 13F filing for Q1 2026, filed 13 May 2026.